Role of circadian clocks in the development and therapeutics of cancer

Journal of International Medical Research

Volumn 39, Issue 6, 2011, Pages 2061-2066

  Huang, X L ^a,b   Fu, C J ^c   Bu, R F ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b The 174th Hospital of Chinese PLA   (China)

^c JINAN MILITARY GENERAL HOSPITAL   (China)

Author keywords

Cancer therapeutics; Circadian clocks; Clock genes; Tumourigenesis

Indexed keywords

DNA TOPOISOMERASE; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN; PER1 PROTEIN; PER2 PROTEIN; PROTEIN BAX; PROTEIN BCL 2; THYMIDYLATE SYNTHASE; TRANSCRIPTION FACTOR;

ALBUMIN D BINDING PROTEIN GENE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER PREVENTION; CANCER RISK; CANCER THERAPY; CARCINOGENESIS; CELL CYCLE REGULATION; CHRONOPHARMACOLOGY; CHRONOTHERAPY; CIRCADIAN RHYTHM; COLORECTAL CANCER; DISEASE ASSOCIATION; DNA REPAIR; DRUG EFFICACY; DRUG METABOLISM; DRUG TARGETING; DRUG TOLERABILITY; GENE; GENE EXPRESSION; GENETIC POLYMORPHISM; HOMING ENDONUCLEASE LIKE FUNCTION GENE; HUMAN; METASTASIS; MOLECULAR CLOCK; NEOPLASM; NEURONAL PAS DOMAIN PROTEIN 2 GENE; NONHUMAN; PER1 GENE; PER2 GENE; PROGNOSIS; PROTEIN BMAL1 GENE; SLEEP WAKING CYCLE; SURVIVAL RATE; TRANSCRIPTION ENHANCER FACTOR GENE; TRANSCRIPTION FACTOR CLOCK GENE;

EID: 84555170243     PISSN: 03000605     EISSN: None     Source Type: Journal    
DOI: 10.1177/147323001103900601     Document Type: Article

References (35)

1. Lowrey PL, Takahashi JS: Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu Rev Genomics Hum Genet 2004; 5: 407-441.
2. 14C-labeled deoxyglucose uptake as a functional marker. Science 1977; 197: 1089-1091.
3. Takahashi JS, Hong HK, Ko CH, et al: The genetics of mammalian circadian order and disorder: implications for physiology and disease. Nat Rev Genet 2008; 9: 764-775.
4. Levi F, Okyar A, Dulong S, et al: Circadian timing in cancer treatments. Annu Rev Pharmacol Toxicol 2010; 50: 377-421.
5. Ko CH, Takahashi JS: Molecular components of the mammalian circadian clock. Hum Mol Genet 2006; 15(spec No 2): R271-R277.
6. Dunlap JC: Molecular bases for circadian clocks. Cell 1999; 96: 271-290.
7. King DP, Zhao Y, Sangoram AM, et al: Positional cloning of the mouse circadian clock gene. Cell 1997; 16: 641-653.
8. Akashi M, Takumi T: The orphan nuclear receptor RORα regulates circadian transcription of the mammalian core-clock Bmal1. Nat Struct Mol Biol 2005; 12: 441-448.
9. Eide EJ, Virshup DM: Casein kinase I: another cog in the circadian clockworks. Chronobiol Int 2001; 18: 389-398.
10. Rafnsson V, Tulinius H, Jonasson JG, et al: Risk of breast cancer in female flight attendants: a population-based study (Iceland). Cancer Causes Control 2001; 12: 95-101.
11. Erren TC, Pape HG, Reiter RJ, et al: Chronodisruption and cancer. Naturwissenschaften 2008; 95: 367-382.
12. Schernhammer ES, Kroenke CH, Laden F, et al: Night work and risk of breast cancer. Epidemiology 2006; 17: 108-111.
13. Viswanathan AN, Hankinson SE, Schernhammer ES: Night shift work and the risk of endometrial cancer. Cancer Res 2007; 67: 10618-10622.
14. Filipski E, Delaunay F, King VM, et al: Effects of chronic jet lag on tumor progression in mice. Cancer Res 2004; 64: 7879-7885.
15. Hoffman AE, Zheng T, Stevens RG, et al: Clock- cancer connection in non-Hodgkin's lymphoma: a genetic association study and pathway analysis of the circadian gene cryptochrome 2. Cancer Res 2009; 69: 3605-3613.
16. Fu L, Pelicano H, Liu J, et al: The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 2002; 111: 41-50.
17. Hoffman AE: CLOCK in breast tumorigenesis: genetic, epigenetic, and transcriptional profiling analyses. Cancer Res 2010; 70: 1459-1468.
18. Gery S, Komatsu N, Baldjyan L, et al: The circadian gene Per1 plays an important role in cell growth and DNA damage control in human cancer cells. Mol Cell 2006; 22: 375-382.
19. Gamsby JJ, Loros JJ, Dunlap JC: A phylogenetically conserved DNA damage response resets the circadian clock. J Biol Rhythms 2009; 24: 193-202.
20. Granda TG, Liu XH, Smaaland R, et al: Circadian regulation of cell cycle and apoptosis proteins in mouse bone marrow and tumor. FASEB J 2005; 19: 304-306.
21. Tampellini M, Filipski E, Liu XH, et al: Docetaxel chronopharmacology in mice. Cancer Res 1998; 58: 3896-3904.
22. Filipski E, Lemaigre G, Liu XH, et al: Circadian rhythm of irinotecan tolerability in mice. Chronobiol Int 2004; 21: 613-630.
23. Wood PA, Du-Quiton J, You S, et al: Circadian clock coordinates cancer cell cycle progression, thymidylate synthase, and 5-fluorouracil therapeutic index. Mol Cancer Ther 2006; 5: 2023-2033.
24. Porsin B, Formento JL, Filipski E, et al: Dihydropyrimidine dehydrogenase circadian rhythm in mouse liver: comparison between enzyme activity and gene expression. Eur J Cancer 2003; 39: 822-828.
25. Longley DB, Harkin DP, Johnston PG: 5-Fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003; 3: 330-338.
26. Kuramoto Y, Hata K, Koyanagi S, et al: Circadian regulation of mouse topoisomerase I gene expression by glucocorticoid hormones. Biochem Pharmacol 2006; 71: 1155-1161.
27. Levi F, Altinok A, Clairambault J, et al: Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Philos Transact A Math Phys Eng Sci 2008; 366: 3575-3598.
28. Kang TH, Reardon JT, Kemp M, et al: Circadian oscillation of nucleotide excision repair in mammalian brain. Proc Natl Acad Sci U S A 2009; 106: 2864-2867.
29. Levi F: Chronotherapeutics: the relevance of timing in cancer therapy. Cancer Causes Control 2006; 17: 611-621.
30. Giacchetti S, Bjarnason G, Garufi C, et al: Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group. J Clin Oncol 2006; 24: 3562-3569.
31. Iurisci I, Filipski E, Sallam H, et al: Liver circadian clock, a pharmacologic target of cyclin-dependent kinase inhibitor seliciclib. Chronobiol Int 2009; 26: 1169-1188.
32. Gachon F, Olela FF, Schaad O, et al: The circadian PAR-domain basic leucine zipper transcription factors DBP, TEF, and HLF modulate basal and inducible xenobiotic detoxification. Cell Metab 2006; 4: 25-36.
33. Gorbacheva VY, Kondratov RV, Zhang R, et al: Circadian sensitivity to the chemotherapeutic agent cyclophosphamide depends on the functional status of the CLOCK/BMAL1 transactivation complex. Proc Natl Acad Sci U S A 2005; 102: 3407-3412.
34. Pogue-Geile KL, Lyons-Weiler J, Whitcomb DC: Molecular overlap of fly circadian rhythms and human pancreatic cancer. Cancer Lett 2006; 243: 55-57.
35. Hrushesky WJ, Grutsch J, Wood P, et al: Circadian clock manipulation for cancer prevention and control and the relief of cancer symptoms. Integr Cancer Ther 2009; 8: 387-397.